Asthma Guidelines from the National Asthma Education and Prevention Program: Where Are We Now?

摘要

The National Asthma Education and Prevention Program Guidelines for the Diagnosis and Management of Asthma were last published in 2007. New therapies and strategies for asthma management have been investigated in the last decade that merit evaluation and inclusion as revision to the guidelines. The National Heart, Lung, and Blood Institute initiated a process for an update on selected topics in 2014 with the final guideline update expected to be published by August 2019. Topics selected for update include the following: Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma; The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management; The Effectiveness of Indoor Allergen Reduction and the Role of Bronchial Thermoplasty in the Management of Asthma; and The Role of Immunotherapy in the Treatment of Asthma. The systematic reviews and meta-analyses of these topics will be published in peer-reviewed journals in 2018.